When is HIT's latest earnings report released?
The most recent financial report for Health in tech, inc. (HIT) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating HIT's short-term business performance and financial health. For the latest updates on HIT's earnings releases, visit this page regularly.
Where does HIT fall in the P/E River chart?
According to historical valuation range analysis, Health in tech, inc. (HIT)'s current price-to-earnings (P/E) ratio is 72.46, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
What is the operating profit of HIT?
According to the latest financial report, Health in tech, inc. (HIT) reported an Operating Profit of 493.52K with an Operating Margin of 5.81% this period, representing a growth of 12.45% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is HIT's revenue growth?
In the latest financial report, Health in tech, inc. (HIT) announced revenue of 8.49M, with a Year-Over-Year growth rate of 90.41%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does HIT have?
As of the end of the reporting period, Health in tech, inc. (HIT) had total debt of 157.6K, with a debt ratio of 0.01. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does HIT have?
At the end of the period, Health in tech, inc. (HIT) held Total Cash and Cash Equivalents of 8.02M, accounting for 0.35 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does HIT go with three margins increasing?
In the latest report, Health in tech, inc. (HIT) achieved the “three margins increasing” benchmark, with a gross margin of 60.6%%, operating margin of 5.81%%, and net margin of 5.3%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess HIT's profit trajectory and future growth potential.
What is the FCF of HIT?
Health in tech, inc. (HIT)'s Free Cash Flow (FCF) for the period is 673.97K, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 68.22% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of HIT?
The latest valuation data shows Health in tech, inc. (HIT) has a Price-To-Earnings (PE) ratio of 72.46 and a Price/Earnings-To-Growth (PEG) ratio of -8.16. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.
